Lucid Diagnostics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Lucid Diagnostics
Tip: Access up to 7 years of quarterly data
All positions including Lucid Diagnostics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lucid Diagnostics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $37k | 36k | 1.01 |
| 2025-03-31 | $69 | 46 | 1.50 |
| 2024-12-31 | $39 | 49 | 0.81 |
| 2024-09-30 | $41 | 51 | 0.82 |
| 2024-06-30 | $40 | 50 | 0.82 |
| 2024-03-31 | $27 | 34 | 0.82 |
| 2023-12-31 | $66 | 47 | 1.40 |
| 2023-09-30 | $14 | 13 | 1.15 |
| 2022-06-30 | $1.0k | 566 | 1.77 |
| 2022-03-31 | $8.0k | 2.4k | 3.38 |
| 2021-12-31 | $23k | 4.4k | 5.26 |